These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
459 related items for PubMed ID: 12490084
21. Evaluation on the immune response induced by DNA vaccine encoding MIC8 co-immunized with IL-12 genetic adjuvant against Toxoplasma gondii infection. Zhao HG, Huang FY, Guo JL, Tan GH. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Aug; 31(4):284-9. PubMed ID: 24812879 [Abstract] [Full Text] [Related]
23. Induction of immune responses in mice by vaccination with Liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes. Chen H, Chen G, Zheng H, Guo H. Chin Med J (Engl); 2003 Oct; 116(10):1561-6. PubMed ID: 14570624 [Abstract] [Full Text] [Related]
24. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ. Vaccine; 2013 Dec 16; 31(52):6225-31. PubMed ID: 24183979 [Abstract] [Full Text] [Related]
25. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Zhang J, He S, Jiang H, Yang T, Cong H, Zhou H, Zhang J, Gu Q, Li Y, Zhao Q. Parasitol Res; 2007 Jul 16; 101(2):331-8. PubMed ID: 17265053 [Abstract] [Full Text] [Related]
26. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Zhou H, Min J, Zhao Q, Gu Q, Cong H, Li Y, He S. Vaccine; 2012 Feb 27; 30(10):1800-6. PubMed ID: 22240340 [Abstract] [Full Text] [Related]
27. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Chen J, Huang SY, Li ZY, Yuan ZG, Zhou DH, Petersen E, Zhang NZ, Zhu XQ. Vaccine; 2013 Mar 25; 31(13):1734-9. PubMed ID: 23370151 [Abstract] [Full Text] [Related]
28. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Chen J, Zhou DH, Li ZY, Petersen E, Huang SY, Song HQ, Zhu XQ. Exp Parasitol; 2014 Apr 25; 139():42-8. PubMed ID: 24602875 [Abstract] [Full Text] [Related]
31. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins. Nie H, Fang R, Xiong BQ, Wang LX, Hu M, Zhou YQ, Zhao JL. Vet Parasitol; 2011 Sep 27; 181(2-4):215-21. PubMed ID: 21632181 [Abstract] [Full Text] [Related]
32. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii. Costa-Silva TA, Meira CS, Ferreira IM, Hiramoto RM, Pereira-Chioccola VL. Exp Parasitol; 2008 Nov 27; 120(3):227-34. PubMed ID: 18706414 [Abstract] [Full Text] [Related]
33. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Cui YL, He SY, Xue MF, Zhang J, Wang HX, Yao Y. Parasite Immunol; 2008 May 27; 30(5):309-13. PubMed ID: 18331395 [Abstract] [Full Text] [Related]
34. [Study on immuno-effect with GRA4 or SAG2 gene recombinant BCG vaccine of Toxoplasma gondii]. Li JH, Wu ST, Weng YB, Gan Y, Liu HB, Liu ML, Zhang RL, Gao ST, Huang DN, Geng YJ. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun 27; 25(3):217-21. PubMed ID: 18038782 [Abstract] [Full Text] [Related]
35. Construction of Toxoplasma gondii SRS29C nucleic acid vaccine and comparative immunoprotective study of an SRS29C and SAG1 combination. Yan A, Tian J, Ye J, Gao C, Ye L, Zhang D, Song Q. Mol Biochem Parasitol; 2024 Sep 27; 259():111630. PubMed ID: 38795969 [Abstract] [Full Text] [Related]
36. Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Hiszczyńska-Sawicka E, Li H, Xu JB, Oledzka G, Kur J, Bickerstaffe R, Stankiewicz M. Exp Parasitol; 2010 Apr 27; 124(4):365-72. PubMed ID: 19962376 [Abstract] [Full Text] [Related]
37. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H. Vaccine; 2011 Jan 17; 29(4):821-30. PubMed ID: 21087690 [Abstract] [Full Text] [Related]
38. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Meng M, He S, Zhao G, Bai Y, Zhou H, Cong H, Lu G, Zhao Q, Zhu XQ. Parasit Vectors; 2012 Nov 26; 5():273. PubMed ID: 23181694 [Abstract] [Full Text] [Related]
39. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide. Sánchez-López EF, Corigliano MG, Albarracín RM, Sander VA, Legarralde A, Bengoa-Luoni SA, Clemente M. Parasit Vectors; 2019 Mar 25; 12(1):140. PubMed ID: 30909938 [Abstract] [Full Text] [Related]
40. [Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30]. Yang TT, He SY, Jiang H, Gu QM, Cong H, Zhou HY, Zhang JQ, Li Y, Zhao QL. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb 28; 23(1):14-7. PubMed ID: 16042200 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]